Pioneering Pharmaceutical Cloud-Intelligent Manufacturing Software Systems
Netorus, a Chinese enterprise founded in 2002 with support from the Shanghai Municipal Government, is a pioneer in pharmaceutical cloud-intelligent manufacturing software systems. Our primary focus lies in the development of comprehensive cloud-based intelligent manufacturing software systems for the pharmaceutical industry, along with advanced process information automation data acquisition and control systems.
As a specialized firm in the pharmaceutical sector, Netorus is dedicated to creating ORP/MES systems that strictly adhere to cGMP/GAMP standards. We were the world’s first company to conceptualize and successfully develop electronic batch production records (eBPR), electronic batch test records (eBTR), electronic regulatory codes, and cloud-intelligent manufacturing, completing rigorous computer system validation.
Currently, Netorus is the sole global provider of a comprehensive cGMP eBPR/eBTR solution, spanning production, quality, and warehousing processes, that has received official audits from the U.S. FDA, EU EMA, and China CFDA. Our Web 2.0 and Industry 4.0-based cloud-intelligent manufacturing technology is unparalleled in the industry.
In May 2009, the Shanghai Scientific and Technical Information Institute, a renowned national authority, conducted a novelty search and determined that our technology had reached an “internationally advanced level.” Netorus is the only software enterprise in China to have successfully transformed high-tech research into practical applications, garnering approval from three major national ministries and serving as a national demonstration project. Most importantly, Netorus’ cloud-intelligent technological innovations represent world-leading research that are entirely owned by China.
Comprehensive Automated Process Control Systems for Top Enterprises
Netorus Technology has successfully assisted numerous top 100 Chinese enterprises in implementing fully automated process information control systems that comply with US/EU cGMP/GAMP regulations. These comprehensive solutions encompass a suite of twelve integrated systems, including:
Netorus ePharma 6cGMP/QbD: A specialized system designed for 6cGMP and Quality by Design (QbD) compliance, ensuring robust and efficient pharmaceutical manufacturing processes.
GAMP PAT/MES Process Analysis and Parameter Release System: Facilitates advanced process analytics, enabling real-time monitoring, control, and release of critical process parameters.
LIMS/cGMP Quality Assurance System: Provides a centralized platform for laboratory information management, ensuring compliance with cGMP quality standards and data integrity.
RFID/MRP Wireless Radio Frequency Material Barcode Management System: Optimizes inventory management and traceability through the use of RFID technology and material barcode tracking.
Netorus Accounting/Financial Cost Management System: Offers comprehensive accounting and financial management solutions, including ABC cost accounting for detailed cost analysis.
These integrated systems provide a holistic approach to process automation, enhancing efficiency, quality, and regulatory compliance. By leveraging cutting-edge technologies and industry best practices, Wang Huan Technology empowers its clients to achieve operational excellence and meet the stringent requirements of global regulatory bodies.
Key benefits of Netorus Technology's solutions include
Enhanced compliance: Streamlined processes and automated data capture ensure adherence to US/EU cGMP/GAMP regulations.
Improved efficiency: Real-time monitoring and control optimize production processes, reducing downtime and increasing throughput.
Enhanced quality: Advanced analytics and data-driven insights enable continuous improvement and the production of high-quality products.
Increased traceability: RFID technology and barcode tracking provide complete visibility into the supply chain.
Reduced costs: Efficient inventory management and accurate cost accounting contribute to significant cost savings.
By partnering with Netorus Technology, Chinese enterprises can achieve a competitive advantage in the global pharmaceutical market.